- Home
- / Spring Bank Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Spring Bank Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.8
2020-11-24
Market Capitalization
$5.2 M
2020-11-24
Revenue
$21.2 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|
| Revenue | 11.3M | 21.2M | ||||
| General and administrative expense | 5.7M | 8.2M | 8.7M | 9.8M | 19.5M | 23.1M |
| Operating expense total | 19.8M | 21.3M | 28.5M | 33.0M | 33.6M | 51.9M |
| EBIT | (19.4M) | (21.3M) | (28.5M) | (33.0M) | (22.4M) | (30.7M) |
| EBIT margin, % | -198.9% | -145.1% | ||||
| Investment income | 96.0K | 369.0K | 999.0K | 1.3M | ||
| Interest income | 1.2M | |||||
| Pre tax profit | (25.6M) | (31.7M) | ||||
| Income tax expense | (1.0K) | (372.0K) | ||||
| Net Income | (17.4M) | (27.7M) | (22.9M) | (24.1M) | (25.6M) | (31.3M) |